Inflammation Clinical Trial
Official title:
Investigating the Neuropathology of Obstructive Sleep Apnoea
Our multi-disciplinary research group works closely with people who have obstructive sleep
apnoea. This is a life-long illness that causes breathing to stop during sleep, which leads
to low-oxygen in the blood. Breathing restarts when the airway at the back of the throat
reopens, usually during arousal from sleep. In some people the repeated arousals from sleep
cause daytime sleepiness. Our research has shown that the low blood oxygen levels affect
thinking and feeling, and in some cases we think it damages the brain cells involved with
memory, attention, emotions and decision-making.
This study will investigate the relationship between the amount of oxygen in the blood and
the loss (if any) of brain cells. Also how the ability to perform complex tasks is affected
in patients that suffer from sleep apnoea. The results will show whether the brain damage in
patients with sleep apnoea can be reversed with treatment. These findings will guide doctors
in the treatment for sleep apnoea and they will cast light onto the process of memory decline
with the aim to preserve brain function.
This is a cross-sectional physiological study, which is anticipated to last for 4 years. In
order to study the mechanism of cognitive dysfunction in Obstructive Sleep Apnoea (OSA),
patients will start Continuous Positive Airway Pressure (CPAP) treatment following the
confirmed diagnosis of sleep apnoea. CPAP is the treatment of choice for patients with
moderate to severe OSA who are sleepy during the day. It is also used in patients with mild
OSA if they are excessively sleepy or suffer from cardiovascular risk factors. It is
recommended by the National Institute for Clinical Excellence (NICE) as a treatment for
adults with moderate or severe OSA (Sleep apnoea - continuous positive airway pressure, NICE
2008). In the proposed study the initiation of CPAP will be within the 18 week period set out
in the National Health Service (NHS) Improvement Plan and Standards for Better Health
(Standards for Better Health, Department of Health 2004). No patient with a diagnosis of OSA
will commence treatment with CPAP later than advised by the NICE guidelines of clinical
judgement for the best interest of the patient.
In order to investigate the neuroinflammation process and discrete changes in the brain of
patients with OSA, a minimum of 9 patients with mild OSA and 9 patients with severe OSA will
be compared to 9 healthy controls following initial sleep (assessment) study. All
participants will undergo a dynamic Positron Emission Tomography with Magnetic Resonance
Imaging (PET-MR) scan with the Translocator protein (TSPO) tracer [Fluorine-18]
N,N-diethyl-2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide
(DPA-714) at the time of enrolment to the study. Each participant will also have an MRI scan
and cognitive testing.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT05910489 -
Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
|